Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer

Xiaolin Yu, Sharad Ghamande, Haitao Liu, Lu Xue, Shuhua Zhao, Wenxi Tan, Lijing Zhao, Shou-Ching Tang, Daqing Wu, Hasan Körkaya,

Molecular Therapy — Nucleic Acids · 2017 · 95 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

breast cancer with intrinsic or acquired resistance to current drugs.

References

35